Researchers from National Institute of Health Sciences (Japan) have published data from a study that aimed to identify novel biomarkers for the diagnosis of diffuse alveolar damage (DAD), a ...

Mutations in the ATP‐binding cassette transporter A3 (ABCA3) gene are increasingly recognised as a significant contributor to interstitial lung disease (ILD) in infants and children. ABCA3 plays a ...

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology. The AT2-like cells ...

Scientists at Boston University and the University of Pennsylvania have used patient-specific induced pluripotent stem cells (iPSCs) to model functional abnormalities of the highly specialized cells, ...

Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes.

Please provide your email address to receive an email when new articles are posted on . Usual interstitial pneumonia was a common finding in lung biopsies of people evaluated for post-COVID-19 ...

Imagine a world where breathing is a luxury and a cough marks the sound of an inner battle. Interstitial lung disease (ILD), a condition characterized by inflammation and fibrosis, is a major cause of ...

The researchers' success in direct reprogramming of mouse fibroblasts into alveolar epithelial-like cells may lead to new treatments for serious lung diseases. Researchers in Japan have successfully ...